Heartland | |
8599 Prairie Trail Dr, Ste A300, Englewood, Colorado 80112 | |
(303) 248-7920 |
Name | Heartland |
---|---|
Organization Name | Pharmease Llc |
Location | 8599 Prairie Trail Dr, Ste A300, Englewood, Colorado 80112 |
Type | Long Term Care Pharmacy |
Phone | (303) 248-7920 |
Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
HemaQuest Pharmaceuticals, Inc., a biotechnology company focused on developing small molecule therapeutics to treat hemoglobin disorders, announced today that clinical investigators have enrolled the first patient in a randomized multi-dose Phase 2 study of HQK-1001 in patients with sickle cell disease.
Recent breakthroughs in HIV prevention research have confirmed the promise of new options to help end the AIDS epidemic and highlight the urgent need for ongoing research to develop additional prevention options and support rapid rollout of proven ones.
The immune systems of HIV patients who are obese don't respond to antiretroviral therapy as well as do those of people of normal weight, according to a study conducted by researchers from the Uniformed Services University of the Health Sciences (USU). The findings were presented by San Diego-based Nancy Crum-Cianflone, MD at the annual meeting of the Infectious Diseases Society of America.
Amilpar, the largest managed care organization in Brazil, in accordance with article 157, paragraph 4, of Law 6,404/76 (Brazilian Corporate Law) and CVM Instruction no. 358/02, informs its shareholders and the market that its subsidiary Amil Assistencia Medica Internacional Ltda. ("Applicant") acquired, in the Public Offer auction (Tag Along) for the acquisition of common shares issued by Medial Saude S.A.
› Verified 8 days ago
NPI Number | 1447001854 |
Organization Name | GUARDIAN PHARMACY OF DENVER, LLC |
Type | Long Term Care Pharmacy |
Address | 8599 Prairie Trail Dr Ste A300, Englewood, CO 80112 |
Phone Number | 303-248-7920 |
News Archive
HemaQuest Pharmaceuticals, Inc., a biotechnology company focused on developing small molecule therapeutics to treat hemoglobin disorders, announced today that clinical investigators have enrolled the first patient in a randomized multi-dose Phase 2 study of HQK-1001 in patients with sickle cell disease.
Recent breakthroughs in HIV prevention research have confirmed the promise of new options to help end the AIDS epidemic and highlight the urgent need for ongoing research to develop additional prevention options and support rapid rollout of proven ones.
The immune systems of HIV patients who are obese don't respond to antiretroviral therapy as well as do those of people of normal weight, according to a study conducted by researchers from the Uniformed Services University of the Health Sciences (USU). The findings were presented by San Diego-based Nancy Crum-Cianflone, MD at the annual meeting of the Infectious Diseases Society of America.
Amilpar, the largest managed care organization in Brazil, in accordance with article 157, paragraph 4, of Law 6,404/76 (Brazilian Corporate Law) and CVM Instruction no. 358/02, informs its shareholders and the market that its subsidiary Amil Assistencia Medica Internacional Ltda. ("Applicant") acquired, in the Public Offer auction (Tag Along) for the acquisition of common shares issued by Medial Saude S.A.
› Verified 8 days ago
NPI Number | 1487918561 |
Organization Name | HEARTLAND PHARMACY - DENVER |
Doing Business As | HEARTLAND PHARMACY DENVER |
Type | Pharmacy |
Address | 8599 Prairie Trail Dr, Ste A300, Englewood, CO 80112 |
Phone Number | 208-552-7677 |
News Archive
HemaQuest Pharmaceuticals, Inc., a biotechnology company focused on developing small molecule therapeutics to treat hemoglobin disorders, announced today that clinical investigators have enrolled the first patient in a randomized multi-dose Phase 2 study of HQK-1001 in patients with sickle cell disease.
Recent breakthroughs in HIV prevention research have confirmed the promise of new options to help end the AIDS epidemic and highlight the urgent need for ongoing research to develop additional prevention options and support rapid rollout of proven ones.
The immune systems of HIV patients who are obese don't respond to antiretroviral therapy as well as do those of people of normal weight, according to a study conducted by researchers from the Uniformed Services University of the Health Sciences (USU). The findings were presented by San Diego-based Nancy Crum-Cianflone, MD at the annual meeting of the Infectious Diseases Society of America.
Amilpar, the largest managed care organization in Brazil, in accordance with article 157, paragraph 4, of Law 6,404/76 (Brazilian Corporate Law) and CVM Instruction no. 358/02, informs its shareholders and the market that its subsidiary Amil Assistencia Medica Internacional Ltda. ("Applicant") acquired, in the Public Offer auction (Tag Along) for the acquisition of common shares issued by Medial Saude S.A.
› Verified 8 days ago
NPI Number | 1861755225 |
Organization Name | HEARTLAND PHARMACY - DENVER |
Doing Business As | HEARTLAND PHARMACY |
Type | Durable Medical Equipment & Medical Supplies Supplier |
Address | 8599 Prairie Trail Dr, Suite A300, Englewood, CO 80112 |
Phone Number | 303-248-7920 |
News Archive
HemaQuest Pharmaceuticals, Inc., a biotechnology company focused on developing small molecule therapeutics to treat hemoglobin disorders, announced today that clinical investigators have enrolled the first patient in a randomized multi-dose Phase 2 study of HQK-1001 in patients with sickle cell disease.
Recent breakthroughs in HIV prevention research have confirmed the promise of new options to help end the AIDS epidemic and highlight the urgent need for ongoing research to develop additional prevention options and support rapid rollout of proven ones.
The immune systems of HIV patients who are obese don't respond to antiretroviral therapy as well as do those of people of normal weight, according to a study conducted by researchers from the Uniformed Services University of the Health Sciences (USU). The findings were presented by San Diego-based Nancy Crum-Cianflone, MD at the annual meeting of the Infectious Diseases Society of America.
Amilpar, the largest managed care organization in Brazil, in accordance with article 157, paragraph 4, of Law 6,404/76 (Brazilian Corporate Law) and CVM Instruction no. 358/02, informs its shareholders and the market that its subsidiary Amil Assistencia Medica Internacional Ltda. ("Applicant") acquired, in the Public Offer auction (Tag Along) for the acquisition of common shares issued by Medial Saude S.A.
› Verified 8 days ago
News Archive
HemaQuest Pharmaceuticals, Inc., a biotechnology company focused on developing small molecule therapeutics to treat hemoglobin disorders, announced today that clinical investigators have enrolled the first patient in a randomized multi-dose Phase 2 study of HQK-1001 in patients with sickle cell disease.
Recent breakthroughs in HIV prevention research have confirmed the promise of new options to help end the AIDS epidemic and highlight the urgent need for ongoing research to develop additional prevention options and support rapid rollout of proven ones.
The immune systems of HIV patients who are obese don't respond to antiretroviral therapy as well as do those of people of normal weight, according to a study conducted by researchers from the Uniformed Services University of the Health Sciences (USU). The findings were presented by San Diego-based Nancy Crum-Cianflone, MD at the annual meeting of the Infectious Diseases Society of America.
Amilpar, the largest managed care organization in Brazil, in accordance with article 157, paragraph 4, of Law 6,404/76 (Brazilian Corporate Law) and CVM Instruction no. 358/02, informs its shareholders and the market that its subsidiary Amil Assistencia Medica Internacional Ltda. ("Applicant") acquired, in the Public Offer auction (Tag Along) for the acquisition of common shares issued by Medial Saude S.A.
› Verified 8 days ago
Accredo Health Group Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 361 Inverness Dr S, Englewood, Colorado 80112 Phone: (303) 799-6550 | |
Cvs Pharmacy #16033 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 6767 S Clinton St, Englewood, Colorado 80112 Phone: (303) 566-0005 | |
Denver Optic Co. Type: Durable Medical Equipment & Medical Supplies Supplier Location: 14 Inverness E Dr D146, Englewood, Colorado 80112 Phone: (303) 649-9494 | |
King Soopers Pharmacy #109 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 5050 S Federal Blvd, Englewood, Colorado 80110 Phone: (303) 794-6397 | |
King Soopers Pharmacy #111 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3475 S University Blvd, Englewood, Colorado 80113 Phone: (303) 806-2770 |